Haematologic Technologies
Business Services · Vermont, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
57 River Rd Unit 1021, Essex Junction, V...Phone Number
(802) 878-1777Website
www.haemtech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Haematologic Technologies
Haematologic Technologies, headquartered in Essex Junction, Vermont, is a leading provider of research reagents, customized blood collection tubes and protein biochemistry services including assay development, validation, and GMP release and stability testing. With a strong protein biochemistry expertise and an emphasis on blood coagulation, the Company provides contract research and development services such as custom protein purification, protein modification, assay development, GMP stability and release testing, and offers over 150 high-quality blood coagulation products including proteins, antibodies, inhibitors and substrates, deficient plasmas, custom IVD/POC reagents, and custom blood/specimen collection tubes.Explore more
Haematologic Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Haematologic Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Haematologic Technologies launches new products
Congratulate Masked Content for being promoted to Masked Content at Haematologic Technologies
Click to see if Haematologic Technologies had a recent Job posting/layoffs
Earning: See what the market has to say on Haematologic Technologies recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Haematologic Technologies has new funding data
Check if Haematologic Technologies has recently received funding, and reach out quickly before it becomes old news!
Check out if Haematologic Technologies is spiking on competitors!
Website visits: Recent activity has been detected on your website
Haematologic Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Haematologic Technologies as Masked Content
Find more new buyers
Compare Similar Companies to Haematologic Technologies
Compare insights from companies similar to Haematologic Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Haematologic Technologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Haematologic Technologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Haematologic Technologies.
Haematologic Technologies financials insights
Gather financial insights about Haematologic Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Haematologic Technologies Tech Stack
A closer look at the technologies used by Haematologic Technologies
Most Recent Scoops
New Hire
Executive Move
Haematologic Technologies has announced that David Halverson has joined the organization as President & Chief Executive Officer.
Event
will be attending the 15th Annual Bioprocessing Summit 2023 conference as an exhibitor. The event will occur from August 14 to August 17, 2023.
Events
New Hire
Executive Move
Joe Flynn has joined the organization as Chief Commercial Officer.
Executive Moves, New Hire
Left Company
Executive Move
Left Company
Management Move
Haematologic Technologies News & Media
Haematologic Technologies Announces Joe Flynn as Chief Commercial Officer
ESSEX JUNCTION, Vt., Jan. 6, 2022 /PRNewswire/ -- Haematologic Technologies ("HT"), a global leader in large molecule analytical services and plasma reagents reagents, today announced the appointment of Joe Flynn as Chief Commercial Officer. Joe will be responsible for the company's sales...Haematologic Technologies Announces John Strokis as Vice President, Quality
ESSEX JUNCTION, Vt., Dec. 16, 2021 /PRNewswire/ -- Haematologic Technologies ("HT"), a global leader in large molecule bioanalysis and biologic reagents, today announced the appointment of John Strokis as Vice President, Quality. John will lead quality initiatives through the next phase...Haematologic Technologies Adds a High Resolution Mass Spectrometry Lab
ESSEX JUNCTION, Vt., Oct. 1, 2020 /PRNewswire/ -- Haematologic Technologies (HTI), a leading protein chemistry company providing products and analytical services supporting the research, development, and commercialization of large molecule biotherapeutics, today announced the addition of...Haematologic Technologies Appoints Steve Pemberton as Vice President of Commercial ...
Just another WordPress site
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Haematologic Technologies
Sign Up For FreeTo access detailed company insights
Haematologic Technologies, headquartered in Essex Junction, Vermont, is a leading provider of research reagents, customized blood collection tubes and protein biochemistry services including assay development, validation, and GMP release and stability testing. With a strong protein biochemistry expertise and an emphasis on blood coagulation, the Co... Read More
